A Comparative Study of Mean Platelet Volume in Diabetic Population With and Without Vascular Complication
Article Sidebar
Main Article Content
https://orcid.org/0000-0003-2587-5391
Ashwath Kumar Chinnaraju Selvakumar Rajabalaji Rajabalaji
Abstract
Diabetes mellitus leads to long-term complications involving multiple organs and systems of the human body. Among the list of complications, a relatively vascular complication increases the morbidity of the condition. Patients with diabetes mellitus are influenced by various factors like hyperglycaemic state, insulin resistance, oxidative stress, and metabolic condition like obesity, and all the mentioned conditions also present with platelet hyperactivity. Mean platelet volume (MPV) can be used as one of the laboratory parameters to know the function and activation of the platelets, which reflects the vascular profile of the patient. So, the present study compares the values of mean platelet volume among the diabetic groups to determine the relation between the vascular complication and the mean platelet volume. This study was conducted with 90 participants, who were divided into three groups. Group A is non-diabetics, group B is type 2 Diabetics, and Group C is type 2 Diabetics with vascular complications and MPV. On analyzing the statistical mean value of mean platelet volume, group B's (type 2 diabetics) value was higher than group A's (non-diabetics) and statistically significant with a p – value of 0.001. Similarly, the mean value of group C (type 2 diabetes with complications) was higher than group B (type 2 diabetics) and statistically significant with a p – value of 0.049 in the diabetics with and without vascular complications. On comparing the MPV of different study groups, the MPV is higher in the diabetic group with complicatiosn compared with the diabetics without complications.
Downloads
Article Details
Copyright (c) 2023 Ajantha Swamy Vasudhevan, Dhivya Mohan Sumathi, Ashwath Kumar Chinnaraju Selvakumar, Rajabalaji Rajabalaji
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific reports. 2020, 10(1), 1-11. DOI: 10.1038/s41598-020-71908-9 DOI: https://doi.org/10.1038/s41598-020-71908-9
Saluja M. Microvascular and macrovascular complications in Diabetes Mellitus: A continuum not distinct?. Cardio-Diabetes Medicine 2021: Clinical Update: Monitor Diabetes Liberate Heart, 2021, 173. DOI: 10.4103/2230-8210.183480 DOI: https://doi.org/10.4103/2230-8210.183480
Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circulation research. 2020. 126(11), 1477-1500. DOI: 10.1161/CIRCRESAHA.120.316101 DOI: https://doi.org/10.1161/CIRCRESAHA.120.316101
Nithya V, Sangavi P, Srinithi R, Nachammai KT, Kumar GS, Prabu D, Langeswaran K. Diabetes and other comorbidities: Microvascular and macrovascular diseases diabetes and cancer. In Advances in Diabetes Research and Management. 2023. (pp. 21-39). Singapore: Springer Nature Singapore. DOI: 10.1007/978-981-19-0027-3_2 DOI: https://doi.org/10.1007/978-981-19-0027-3_2
Cognasse F, Laradi S, Berthelot P, Bourlet T, Marotte H, Mismetti P, Hamzeh-Cognasse H. Platelet inflammatory response to stress. Frontiers in immunology. 2019. 10, 1478. DOI: 10.3389/fimmu.2019.01478 DOI: https://doi.org/10.3389/fimmu.2019.01478
Senchenkova EY, Russell J, Yildirim A, Granger DN, Gavins FN. Novel Role of T Cells and IL-6 (Interleukin-6) in angiotensin II–induced microvascular dysfunction. Hypertension. 2019. 73(4), 829-838. DOI: 10.1161/HYPERTENSIONAHA.118.12286
Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes care. 2009 Apr 1;32(4):525-7. DOI: 10.2337/dc08-1865 DOI: https://doi.org/10.2337/dc08-1865
Naghipour Hamzekolaei M, Jafarisani M, Farajzadeh A, Aghayan SS, Atashi A, Yarmohammadi M, Sadeghi I, Tashakori M. Changes in mean platelet volume and hematologic indices in patients with panic disorder due to oxidative stress. Brain and Behavior. 2020 Apr;10(4):e01569. DOI: 10.1002/brb3.1569 DOI: https://doi.org/10.1002/brb3.1569
Senchenkova EY, Russell J, Yildirim A, Granger DN, Gavins, FN. Novel Role of T Cells and IL-6 (Interleukin-6) in angiotensin II–induced microvascular dysfunction. Hypertension. 2019. 73(4), 829-838. DOI: 10.1161/HYPERTENSIONAHA.118.12286 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.118.12286
Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovascular diabetology. 2018 Dec;17(1):1-7. DOI: 10.1186/s12933-018-0763-3 DOI: https://doi.org/10.1186/s12933-018-0763-3
Pafili K, Penlioglou T, Mikhailidis DP, Papanas N. Mean platelet volume and coronary artery disease. Current opinion in cardiology. 2019. 34(4), 390-398. DOI: 10.1097/HCO.0000000000000624 DOI: https://doi.org/10.1097/HCO.0000000000000624
Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators of inflammation. 2019. 2019. DOI: 10.1155/2019/9213074 DOI: https://doi.org/10.1155/2019/9213074
Abeles RD, Mullish BH, Forlano R, Kimhofer T, Adler M, Tzallas A, Manousou P. Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume. Alimentary pharmacology & therapeutics. 2019. 49(8), 1077-1085. DOI: 10.1111/apt.15192 DOI: https://doi.org/10.1111/apt.15192
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021 Jan 1;44(Supplement 1):S15-33. DOI: https://diabetesjournals.org/care/article/44/Supplement_1/S15/30859/2-Classification-and-Diagnosis-of-Diabetes DOI: https://doi.org/10.2337/dc21-S002
Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2009 Mar 1;23(2):89-94. DOI: 10.1016/j.jdiacomp.2008.01.006 DOI: https://doi.org/10.1016/j.jdiacomp.2008.01.006
Bhatta S, Singh S, Gautam S, Osti BP. Mean platelet volume and platelet count in patients with type 2 diabetes mellitus and impaired fasting glucose. Journal of Nepal Health Research Council. 2018. 16(41), 392-395. DOI: 10.33314/jnhrc.1502 DOI: https://doi.org/10.33314/jnhrc.v16i41.1502
Mitchell RN. Hemodynamic disorders, thromboembolic disease, and shock. Robbins and Cotran pathologic basis of disease. 2005;8:111-34.DOI: https://semmelweis.hu/patologia2/files/2014/09/3_hemodyn_1_en_17_18.pdf
Zhang Y, Chen R, Jia Y, Chen M, Shuai Z. Effects of exenatide on coagulation and platelet aggregation in patients with type 2 diabetes. Drug Design. 2021. Development and Therapy, 3027-3040. DOI: 10.2147/DDDT.S312347 DOI: https://doi.org/10.2147/DDDT.S312347
Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, Singh S. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011 Mar 1;16(2):86-9. DOI: 10.1179/102453311X12902908412110 DOI: https://doi.org/10.1179/102453311X12902908412110
Bilgin S, Aktaş G, Kahveci G, Atak Tel BM, Kurtkulağı Ö, Duman Taslamacıoğlu T. Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus?. Bratislava Medical Journal. 2021. DOI: 10.4149/BLL_2021_017 DOI: https://doi.org/10.4149/BLL_2021_017
Inoue H, Saito M, Kouchi K, Asahara SI, Nakamura F, Kido Y. Association between mean platelet volume in the pathogenesis of type 2 diabetes mellitus and diabetic macrovascular complications in Japanese patients. Journal of Diabetes Investigation. 2020. 11(4), 938-945. DOI: 10.1111/jdi.13198 DOI: https://doi.org/10.1111/jdi.13198
Shilpi K, Potekar RM. A study of platelet indices in type 2 diabetes mellitus patients. Indian Journal of Hematology and Blood Transfusion. 2018 Jan;34(1):115-20.DOI: 10.1007/s12288-017-0825-9 DOI: https://doi.org/10.1007/s12288-017-0825-9
Véricel E, Januel C, Carreras M, Moulin P, Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes. 2004 Apr 1;53(4):1046-51. DOI: 10.2337/diabetes.53.4.1046 DOI: https://doi.org/10.2337/diabetes.53.4.1046
Ji S, Zhang J, Fan X, Wang X, Ning X, Zhang B, Yan H. The relationship between mean platelet volume and diabetic retinopathy: a systematic review and meta-analysis. Diabetology & metabolic syndrome. 2019. 11, 1-8. DOI: 10.1186/s13098-019-0420-3 DOI: https://doi.org/10.1186/s13098-019-0420-3
Goyal P, Mahajan S, Parmar C. Evaluation of platelet function in subjects with type-2 diabetes mellitus: A case control study. National Journal of Physiology, Pharmacy and Pharmacology. 2020. 10(8), 667-667. DOI: 10.5455/njppp.2020.10.03057202014052020 DOI: https://doi.org/10.5455/njppp.2020.10.03057202014052020
Gohil A, Dhotre S, Faldu B, Goswami H. Study of platelet indices in diabetes mellitus patient with respect to HbA1c and its correlation with diabetic complications. Diabetic foot. 2021. 30, 30-61. DOI: 10.33545/pathol.2021.v4.i3b.391 DOI: https://doi.org/10.33545/pathol.2021.v4.i3b.391
